These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies. Roemer SN; Brendel M; Gnörich J; Malpetti M; Zaganjori M; Quattrone A; Gross M; Steward A; Dewenter A; Wagner F; Dehsarvi A; Ferschmann C; Wall S; Palleis C; Rauchmann BS; Katzdobler S; Jäck A; Stockbauer A; Fietzek UM; Bernhardt AM; Weidinger E; Zwergal A; Stöcklein S; Perneczky R; Barthel H; Sabri O; Levin J; Höglinger GU; Franzmeier N Brain; 2024 Jul; 147(7):2428-2439. PubMed ID: 38842726 [TBL] [Abstract][Full Text] [Related]
6. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [ Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J; Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820 [TBL] [Abstract][Full Text] [Related]
7. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study. Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450 [TBL] [Abstract][Full Text] [Related]
16. Tau deposition patterns are associated with functional connectivity in primary tauopathies. Franzmeier N; Brendel M; Beyer L; Slemann L; Kovacs GG; Arzberger T; Kurz C; Respondek G; Lukic MJ; Biel D; Rubinski A; Frontzkowski L; Hummel S; Müller A; Finze A; Palleis C; Joseph E; Weidinger E; Katzdobler S; Song M; Biechele G; Kern M; Scheifele M; Rauchmann BS; Perneczky R; Rullman M; Patt M; Schildan A; Barthel H; Sabri O; Rumpf JJ; Schroeter ML; Classen J; Villemagne V; Seibyl J; Stephens AW; Lee EB; Coughlin DG; Giese A; Grossman M; McMillan CT; Gelpi E; Molina-Porcel L; Compta Y; van Swieten JC; Laat LD; Troakes C; Al-Sarraj S; Robinson JL; Xie SX; Irwin DJ; Roeber S; Herms J; Simons M; Bartenstein P; Lee VM; Trojanowski JQ; Levin J; Höglinger G; Ewers M Nat Commun; 2022 Mar; 13(1):1362. PubMed ID: 35292638 [TBL] [Abstract][Full Text] [Related]
17. Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [ Hong J; Lu J; Liu F; Wang M; Li X; Clement C; Lopes L; Brendel M; Rominger A; Yen TC; Guan Y; Tian M; Wang J; Zuo C; Shi K; EBioMedicine; 2023 Nov; 97():104835. PubMed ID: 37839135 [TBL] [Abstract][Full Text] [Related]
18. A Machine Learning-Based Approach to Discrimination of Tauopathies Using [ Endo H; Tagai K; Ono M; Ikoma Y; Oyama A; Matsuoka K; Kokubo N; Hirata K; Sano Y; Oya M; Matsumoto H; Kurose S; Seki C; Shimizu H; Kakita A; Takahata K; Shinotoh H; Shimada H; Tokuda T; Kawamura K; Zhang MR; Oishi K; Mori S; Takado Y; Higuchi M Mov Disord; 2022 Nov; 37(11):2236-2246. PubMed ID: 36054492 [TBL] [Abstract][Full Text] [Related]
19. In vivo binding of a tau imaging probe, [ Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739 [TBL] [Abstract][Full Text] [Related]
20. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy. Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]